US Stock MarketDetailed Quotes
NDRAW Endra Life Sciences Inc C/Wts 08/05/2022 (To Pur Com)
- 0.000
- 0.0000.00%
Close Dec 4 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.03052wk High0.00P/B0Float Cap0.01052wk Low--Dividend TTM0Shs Float2.000Historical High--Div YieldTTM0.00%Amplitude0.010Historical Low--Avg Price1Lot Size
Endra Life Sciences Inc C/Wts 08/05/2022 (To Pur Com) Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -6.00%-3.1M | -3.50%-11.12M | -27.96%-2.65M | -28.75%-2.75M | 18.90%-2.8M | 5.34%-2.92M | -25.12%-10.75M | -8.68%-2.07M | 14.07%-2.13M | -108.19%-3.45M |
| Net income from continuing operations | -25.95%-2.86M | 4.22%-11.23M | -37.94%-3.1M | 18.41%-2.66M | -10.55%-3.2M | 31.71%-2.27M | 11.88%-11.73M | 53.20%-2.25M | 4.56%-3.26M | -23.97%-2.89M |
| Operating gains losses | ---- | ---308.6K | --0 | --0 | --0 | ---308.6K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 6.84%52.22K | 35.80%224.42K | -24.70%53.67K | 246.31%61.51K | 55.94%60.37K | 30.33%48.87K | 43.68%165.25K | 28.80%71.28K | -10.88%17.76K | 92.48%38.71K |
| Other non cash items | ---- | ---- | ---- | 31.36%-705.03K | 29.20%658.79K | -94.07%46.25K | -93.81%232.43K | -101.50%-30K | -194.27%-1.03M | 42.85%509.9K |
| Change In working capital | 23.77%-581.42K | 17.07%-1.26M | 94.25%-23.38K | -183.14%-477.83K | 100.22%2.49K | -30.88%-762.68K | -354.44%-1.52M | -168.84%-406.74K | 421.81%574.74K | -469.58%-1.11M |
| -Change in inventory | -371.34%-645.68K | -45.95%-694.96K | 180.76%215.17K | -1,100.93%-174.95K | -260.89%-598.18K | -122.77%-136.99K | -781.84%-476.18K | -1,951.50%-266.41K | 132.64%17.48K | -2,762,433.33%-165.75K |
| -Change in prepaid assets | 174.38%286.6K | -249.28%-957.2K | -200.03%-170.8K | -141.44%-208.28K | 72.09%-192.83K | -50.21%-385.29K | -1,055.71%-274.05K | 89.92%170.75K | 1,253.82%502.59K | -398.08%-690.89K |
| -Change in payables and accrued expense | 14.73%-190.6K | 158.82%491.1K | 90.36%-37.69K | -232.78%-65.74K | 448.41%818.07K | 13.65%-223.53K | -209.85%-834.99K | -173.67%-390.82K | 130.53%49.51K | -144.20%-234.8K |
| -Change in other current assets | ---- | --0 | --0 | --0 | ---- | ---- | 216.95%124.72K | 803.66%95.47K | --20.5K | --0 |
| -Change in other current liabilities | -88.18%-31.74K | -65.53%-100.34K | -91.09%-30.05K | -88.15%-28.86K | -64.17%-24.56K | -15.59%-16.87K | -99.74%-60.62K | 48.18%-15.73K | ---15.34K | ---14.96K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -6.00%-3.1M | -3.50%-11.12M | -27.96%-2.65M | -28.75%-2.75M | 18.90%-2.8M | 5.34%-2.92M | -25.12%-10.75M | -8.68%-2.07M | 14.07%-2.13M | -108.19%-3.45M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -98.56%-89.35K | 40.27%-45K | 0 | 0 | 0 | -101.34%-45K | -72.80%-75.33K | -69.07%-64.85K | 11.87K | 0 |
| Net PPE purchase and sale | -98.56%-89.35K | 40.27%-45K | --0 | --0 | --0 | -101.34%-45K | -72.80%-75.33K | -69.07%-64.85K | --11.87K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -98.56%-89.35K | 40.27%-45K | --0 | --0 | --0 | -101.34%-45K | -72.80%-75.33K | -69.07%-64.85K | --11.87K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -93.21%854.05K | 12.86%13.4M | -94.24%321.08K | -90.39%496.61K | 0 | 31,970.75%12.58M | 42.47%11.88M | -4.67%5.57M | 107.44%5.17M | 1.1M |
| Net issuance payments of debt | ---- | --0 | --0 | --0 | ---- | ---- | -86.47%337.08K | --0 | -98.30%42.26K | ---- |
| Net common stock issuance | -91.28%854.05K | 56.56%10.62M | -94.12%321.08K | -6.37%496.61K | --0 | --9.8M | 5,324.75%6.78M | 4,267.24%5.46M | --530.42K | --791.47K |
| Proceeds from stock option exercised by employees | --0 | -41.44%2.79M | --0 | --0 | --0 | 6,999.31%2.79M | --4.76M | --112.93K | --4.59M | --11.2K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -93.21%854.05K | 12.86%13.4M | -94.24%321.08K | -90.39%496.61K | --0 | 31,970.75%12.58M | 42.47%11.88M | -4.67%5.57M | 107.44%5.17M | --1.1M |
| Net cash flow | ||||||||||
| Beginning cash position | 30.91%9.46M | 17.06%7.23M | 210.90%11.79M | 1,776.04%14.04M | 442.84%16.84M | 17.06%7.23M | -4.59%6.17M | 66.72%3.79M | -66.99%748.56K | -20.96%3.1M |
| Current changes in cash | -124.28%-2.33M | 112.15%2.23M | -167.90%-2.33M | -173.90%-2.25M | -18.91%-2.8M | 413.06%9.62M | 454.38%1.05M | -11.92%3.43M | 39,075.66%3.04M | -41.99%-2.35M |
| End cash Position | -57.68%7.13M | 30.91%9.46M | 30.91%9.46M | 210.90%11.79M | 1,776.04%14.04M | 442.84%16.84M | 17.06%7.23M | 17.06%7.23M | 66.72%3.79M | -66.99%748.56K |
| Free cash flow | -7.40%-3.19M | -3.19%-11.17M | -24.08%-2.65M | -29.47%-2.75M | 18.90%-2.8M | 4.57%-2.97M | -25.36%-10.82M | -9.87%-2.14M | 14.55%-2.12M | -108.19%-3.45M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data